W. Kwasny

6.5k total citations · 1 hit paper
56 papers, 3.5k citations indexed

About

W. Kwasny is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. Kwasny has authored 56 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 31 papers in Cancer Research and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. Kwasny's work include Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (15 papers) and Estrogen and related hormone effects (14 papers). W. Kwasny is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (15 papers) and Estrogen and related hormone effects (14 papers). W. Kwasny collaborates with scholars based in Austria, United States and Germany. W. Kwasny's co-authors include R. Jakesz, Michael Gnant, Hellmut Samonigg, Richard Greil, E. Kubista, Michael Seifert, K. Haider, Christian Menzel, Christoph Tausch and Brigitte Mlineritsch and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

W. Kwasny

55 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

2005 642 citations R. Jakesz, W. Jonat et al. The Lancet profile →

Peers

Countries citing papers authored by W. Kwasny

Since Specialization

Citations

This map shows the geographic impact of W. Kwasny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Kwasny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Kwasny more than expected).

Fields of papers citing papers by W. Kwasny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Kwasny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Kwasny. The network helps show where W. Kwasny may publish in the future.

Co-authorship network of co-authors of W. Kwasny

This figure shows the co-authorship network connecting the top 25 collaborators of W. Kwasny. A scholar is included among the top collaborators of W. Kwasny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Kwasny. W. Kwasny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer 2019 ·The Breast ·Christian F. Singer, Martin Filipits, Stephan Jahn, Luca Abete, R. Jakesz, Richard Greil, Thomas Bauernhofer, W. Kwasny, Michael Seifert, Florian Fitzal, (unknown), Manfred Schmitt, Farid Moinfar, Michael Gnant	7
2	Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study 2016 ·Annals of Oncology ·Guenther G. Steger, Edgar Petru, Ferdinand Haslbauer, Daniel Egle, A. Galid, Thamer Sliwa, Alois Lang, Thomas Kühr, Andreas Petzer, Reinhard Ruckser, Brigitte Mlineritsch, Richard Greil, Michael Seifert, Christian F. Singer, Johannes Andel, W. Kwasny, Christian Marth, (unknown), Christoph Tinchon, Rupert Bartsch	2
3	The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial 2013 ·British Journal of Cancer ·(unknown), Michael Gnant, Georg Pfeiler, Herbert Stöger, Brigitte Mlineritsch, Florian Fitzal, Marija Balić, W. Kwasny, Michael Seifert, M. Stierer, Peter Dubsky, Richard Greil, Guenther G. Steger, H. Samonigg, Christian Fesl, R. Jakesz	43
4	Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial 2011 ·The Lancet Oncology ·Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, G. Luschin-Ebengreuth, Dietmar Heck, Christian Menzel, R. Jakesz, Michael Seifert, Michael Hubalek, Gunda Pristauz, Thomas Bauernhofer, Holger Eidtmann, W. Eiermann, Guenther G. Steger, W. Kwasny, Peter Dubsky, (unknown), (unknown), Christian Fesl, Richard Greil	335
5	Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Richard Pötter, Michael Gnant, W. Kwasny, Christoph Tausch, L. Handl-Zeller, B. Pakisch, Susanne Taucher, J. Hammer, G. Luschin-Ebengreuth, Marianne Schmid, Felix Sedlmayer, M. Stierer, G. Reiner, Karin S. Kapp, F Hofbauer, Andrea Rottenfusser, Sabine Pöstlberger, K. Haider, Wolfgang Draxler, R. Jakesz	152
6	Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a 2007 ·JNCI Journal of the National Cancer Institute ·R. Jakesz, Richard Greil, Michael Gnant, Marianne Schmid, W. Kwasny, E. Kubista, Brigitte Mlineritsch, C. Tausch, M. Stierer, F Hofbauer, K. Edward Renner, Ch. Dadak, Ernst Rücklinger, H. Samonigg, (unknown)	214
7	Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer 2006 ·Acta Oncologica ·H. Ulrich-Pur, Gabriela Kornek, K. Haider, W. Kwasny, (unknown), (unknown), Laurenz Vormittag, D. Depisch, Fritz Lang, Werner Scheithauer	10
8	Lumpectomy Plus Tamoxifen or Arimidex With or Without Whole Breast Irradiation in Women with Favorable Early Breast Cancer 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Richard Poetter, Michael Gnant, W. Kwasny, (unknown), L. Handl-Zeller, (unknown), B. Pakisch, G. Luschin-Ebengreuth, (unknown), M. Stierer, Wolfgang Draxler, R. Jakesz	0
9	Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial breakdown → 2005 ·The Lancet ·R. Jakesz, W. Jonat, Michael Gnant, Martina Mittlboeck, Richard Greil, Christoph Tausch, Joern Hilfrich, W. Kwasny, Christian Menzel, Hellmut Samonigg, Michael Seifert, G. Gademann, Manfred Kaufmann	642
10	Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma 2003 ·British Journal of Cancer ·H. Ulrich-Pur, Markus Raderer, Gabriela Kornek, B. Schüll, Katharina Schmid, K. Haider, W. Kwasny, D. Depisch, Bruno Schneeweiß, Fritz Lang, Werner Scheithauer	98
11	Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. 2002 ·PubMed ·Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg, H. Hausmaninger, W. Kwasny, Michael Gnant, R. Jakesz, E. Kubista, Peter Birner, Georg Oberhuber	332
12	Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial 2002 ·Annals of Oncology ·Werner Scheithauer, B. Schüll, H. Ulrich-Pur, Katharina Schmid, Markus Raderer, K. Haider, W. Kwasny, D. Depisch, Bruno Schneeweiß, Friedrich Lang, Gabriela Kornek	149
13	Zwischenbericht über die Anwendung des ‘Advanced Breast Biopsy Instrumentation’- Systems im Rahmen einer Multizenterstudie 2002 ·Gyn�kologisch-geburtshilfliche Rundschau ·W. Kwasny, (unknown), A. Haid, M. Stierer, P. Konstantiniuk, (unknown), P. Sevelda	1
14	Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. 2001 ·PubMed ·P. Birner, Georg Oberhuber, Josefine Stani, (unknown), H. Samonigg, H. Hausmaninger, E. Kubista, W. Kwasny, Daniela Kandioler-Eckersberger, Michael Gnant, R. Jakesz	159
15	Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma 2001 ·Cancer ·Werner Scheithauer, (unknown), H. Ulrich-Pur, (unknown), (unknown), (unknown), K. Haider, W. Kwasny, D. Depisch	39
16	Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin 2000 ·British Journal of Cancer ·Gabriela Kornek, (unknown), A Marczell, D. Depisch, J. Karner, (unknown), K. Haider, W. Kwasny, Gottfried J. Locker, Werner Scheithauer	46
17	Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor 2000 ·Breast Cancer Research and Treatment ·W. Kwasny, Gabriela Kornek, K. Haider, Julia Valencak, H. Ulrich-Pur, (unknown), Friedrich Lang, D. Depisch, Werner Scheithauer	3
18	Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor 1999 ·Breast Cancer Research and Treatment ·K. Haider, Gabriela Kornek, W. Kwasny, (unknown), Julia Valencak, Friedrich Lang, (unknown), E. Kovats, D. Depisch, Werner Scheithauer	39
19	A Phase l/ll Study of Quinidine, a Potential Multidrug Resistance-Reversing Agent, in Combination with Pirarubicin in Patients with Advanced Refractory Breast Cancer 1993 ·Oncology Research and Treatment ·Markus Raderer, D. Depisch, K. Haider, W. Kwasny, (unknown), Werner Scheithauer	4
20	Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C 1993 ·Breast Cancer Research and Treatment ·Werner Scheithauer, Gabriela Kornek, K. Haider, W. Kwasny, Thomas Schenk, Robert Pirker, D. Depisch	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact